When metformin monotherapy is inadequate for type 2 diabetes mellitus patients; linagliptin in combination with metformin is as efficacious as, but safer than, glimepiride.
Friday, 20 July 2012
Safety Comparison of Linagliptin and Glimepiride in Type 2 Diabetes Patients | Medindia
Safety Comparison of Linagliptin and Glimepiride in Type 2 Diabetes Patients | Medindia
When metformin monotherapy is inadequate for type 2 diabetes mellitus patients; linagliptin in combination with metformin is as efficacious as, but safer than, glimepiride.
http://www.medindia.net/news/healthwatch/safety-comparison-of-linagliptin-and-glimepiride-in-type-2-diabetes-patients-104344-1.htm
When metformin monotherapy is inadequate for type 2 diabetes mellitus patients; linagliptin in combination with metformin is as efficacious as, but safer than, glimepiride.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment